The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(2-(8-(dimethylamino)-3-oxo-8-phenyl-2-azaspiro[4.5]decan-2-yl)ethyl)cyclobutanecarbonitrile ID: ALA4536065
PubChem CID: 118662159
Max Phase: Preclinical
Molecular Formula: C24H33N3O
Molecular Weight: 379.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)C1(c2ccccc2)CCC2(CC1)CC(=O)N(CCC1(C#N)CCC1)C2
Standard InChI: InChI=1S/C24H33N3O/c1-26(2)24(20-7-4-3-5-8-20)13-11-23(12-14-24)17-21(28)27(19-23)16-15-22(18-25)9-6-10-22/h3-5,7-8H,6,9-17,19H2,1-2H3
Standard InChI Key: ZYUUMWBXZQRLNX-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
16.8902 -8.9911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4775 -9.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1833 -10.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5960 -9.4039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1120 -7.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5165 -8.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3254 -8.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7360 -7.6422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3315 -6.9364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5165 -6.9322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5675 -7.0190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8123 -7.3463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8902 -8.1656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.6935 -8.3446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3118 -7.0576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1027 -7.2630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0943 -6.2699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3118 -8.2173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0987 -9.0038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6737 -9.5787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4606 -9.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6694 -8.5768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0928 -8.0054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2776 -8.7064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5029 -8.4462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1156 -8.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3433 -8.4655 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1020 -6.9267 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
5 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 5 1 0
8 15 1 0
15 16 1 0
15 17 1 0
8 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
13 24 1 0
24 25 1 0
25 1 1 0
1 26 1 0
26 27 3 0
12 28 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.55Molecular Weight (Monoisotopic): 379.2624AlogP: 4.32#Rotatable Bonds: 5Polar Surface Area: 47.34Molecular Species: BASEHBA: 3HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.93CX LogP: 3.37CX LogD: 0.88Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.77Np Likeness Score: 0.26
References 1. Rosse G.. (2016) Treatment of Pain with Spirocylic Cyclohexane Derivatives Having Dual Specificity for ORL-1 and μ-Opioid Receptors., 7 (9): [PMID:27660683 ] [10.1021/acsmedchemlett.6b00277 ]